Atlas Trials

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)

Clinical trial NCT03075904 · TERMINATED

Trial details

NCT number
NCT03075904
Sponsor
Alexion Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
PemphigusPemphigus VulgarisPemphigus Foliaceus
Start date
2017-07-18
Primary completion
2019-01-16
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.